Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F16%3A43915350" target="_blank" >RIV/00023752:_____/16:43915350 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/67985823:_____/16:00471693 RIV/61388963:_____/16:00471693

Výsledek na webu

<a href="https://register.epo.org/application?number=EP10744655" target="_blank" >https://register.epo.org/application?number=EP10744655</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them

Popis výsledku v původním jazyce

The presented invention applies to the compounds with general formula (I), where R1 stands for as mentioned previously in the compound specifications, the production process of the compounds with general formula (I), where R1 stands for as mentioned previously in the compound specifications, application of the compounds with general formula (I) in treatment of various diseases of central nervous system, in treatment of neuropsychiatric disorders related to imbalance of glutamatergic neurotransmitter system, ischemic damage of CNS, neurodegenerative changes and disorders of CNS, affective disorders, depression, PTSD and other diseases related to stress, anxiety, schizophrenia and psychotic disorders, pain, addictions, multiple sclerosis, epilepsy and gliomas. This invention further applies to the compounds with general formula (I) used for production of veterinary and human pharmaceutical preparations used in treatment of above mentioned diseases as well as in production of substances used in experimental research, analytic chemistry, dietary supplements or cosmetic preparations.

Název v anglickém jazyce

Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them

Popis výsledku anglicky

The presented invention applies to the compounds with general formula (I), where R1 stands for as mentioned previously in the compound specifications, the production process of the compounds with general formula (I), where R1 stands for as mentioned previously in the compound specifications, application of the compounds with general formula (I) in treatment of various diseases of central nervous system, in treatment of neuropsychiatric disorders related to imbalance of glutamatergic neurotransmitter system, ischemic damage of CNS, neurodegenerative changes and disorders of CNS, affective disorders, depression, PTSD and other diseases related to stress, anxiety, schizophrenia and psychotic disorders, pain, addictions, multiple sclerosis, epilepsy and gliomas. This invention further applies to the compounds with general formula (I) used for production of veterinary and human pharmaceutical preparations used in treatment of above mentioned diseases as well as in production of substances used in experimental research, analytic chemistry, dietary supplements or cosmetic preparations.

Druh

P - Patent

CEP obor

—

OECD FORD obor

30104 - Pharmacology and pharmacy

Projekt

<a href="/cs/project/LO1611" target="_blank" >LO1611: Udržitelnost pro Národní ústav duševního zdraví</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Číslo patentu nebo vzoru

EP2435463

Vydavatel

EPO_1 -

Název vydavatele

European Patent Office

Místo vydání

Munich, The Hague, Berlin, Vienna, Brussels

Stát vydání

—

Datum přijetí

12. 10. 2016

Název vlastníka

Ústav organické chemie a biochemie AV ČR, v. v. i. [CZ]; Fyziologický ústav AV ČR, v. v. i. [CZ]; Národní ústav duševního zdraví [CZ]

Způsob využití

A - Výsledek využívá pouze poskytovatel

Druh možnosti využití

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence